Novo Nordisk is committed to and encourages the safe and proper disposal of our products by patients. Novo Nordisk's product portfolio includes several injectable medications (in both vial and pen device) that require the use of needles, as well as pen needles. Our injectable medicines are all distributed with FDA-approved instructions for use that educate patients regarding the proper disposal of our products after use, including directing them to any state or local laws governing disposal.
Under California and Minnesota law, pharmaceutical manufacturers like Novo Nordisk are required to provide a description of the actions, if any, that they have taken to support the safe collection and proper disposal of sharps, which include needles, pen needles and similar devices, used with medications intended to be self-injected at home. Senate Bill 486, Code sections 47115 - 47116; Minnesota 2010, Chapter 286, S.F. No. 1323. A copy of the report can be accessed on the right side of this page.